Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prophylactic Role of Liposomized Chloroquine Against Murine Cryptococcosis Less Susceptible to Fluconazole

Identifieur interne : 000249 ( an2020/Analysis ); précédent : 000248; suivant : 000250

Prophylactic Role of Liposomized Chloroquine Against Murine Cryptococcosis Less Susceptible to Fluconazole

Auteurs : Masood A. Khan [Inde, États-Unis] ; Rukhsana Jabeen [Inde] ; Owais Mohammad [Inde]

Source :

RBID : ISTEX:9917EB17E63B7F8CFEB78FB799F6C00F609F95E3

English descriptors

Abstract

No Heading: Purpose.: The prophylactic role of liposomized chloroquine (lip-CQ) has been assessed against less susceptible Cryptococcus neoformans infection in murine model. Methods.: In the current study, we investigated the antifungal activity of lip-CQ against C. neoformans in macrophages cell line (J 774) and murine model. Mice were pretreated with free as well as liposomized formulations of CQ at various doses. The anticryptococcal activity of fluconazole was compared in mice with or without CQ pretreatment. The efficacy of CQ prophylaxis was assessed by survival as well as colony forming units (cfu) in brain and lungs of treated mice. Results.: Fluconazole alone was not found significantly effective against C. neoformans in both in vitro and in vivo studies. However, the antifungal activity of fluconazole increases in chloroquine-pretreated mice. Lip-CQ was found to be more effective in comparison to the same dose of free chloroquine in reducing fungal burden from macrophages in vitro and lungs and brain of C. neoformans infected mice. Conclusions.: The enhanced prophylactic activity of lip-CQ seems due to rapid uptake of drug-containing liposomes by macrophages. The liposome-mediated accumulation of CQ in macrophages makes the environment unfavorable (alkaline) for the intracellular multiplication of C. neoformans. Moreover, the increased incidence of multidrug resistance and diversity of pathogenic microorganisms inhibited or killed by CQ makes it the drug of choice for prophylactic therapy.

Url:
DOI: 10.1007/s11095-004-7672-8


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:9917EB17E63B7F8CFEB78FB799F6C00F609F95E3

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Prophylactic Role of Liposomized Chloroquine Against Murine Cryptococcosis Less Susceptible to Fluconazole</title>
<author>
<name sortKey="Khan, Masood A" sort="Khan, Masood A" uniqKey="Khan M" first="Masood A." last="Khan">Masood A. Khan</name>
</author>
<author>
<name sortKey="Jabeen, Rukhsana" sort="Jabeen, Rukhsana" uniqKey="Jabeen R" first="Rukhsana" last="Jabeen">Rukhsana Jabeen</name>
</author>
<author>
<name sortKey="Mohammad, Owais" sort="Mohammad, Owais" uniqKey="Mohammad O" first="Owais" last="Mohammad">Owais Mohammad</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9917EB17E63B7F8CFEB78FB799F6C00F609F95E3</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1007/s11095-004-7672-8</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-W5J1JTJ7-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000429</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000429</idno>
<idno type="wicri:Area/Istex/Curation">000429</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E05</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E05</idno>
<idno type="wicri:doubleKey">0724-8741:2004:Khan M:prophylactic:role:of</idno>
<idno type="wicri:Area/Main/Merge">001F79</idno>
<idno type="wicri:Area/Main/Curation">001F64</idno>
<idno type="wicri:Area/Main/Exploration">001F64</idno>
<idno type="wicri:Area/an2020/Extraction">000249</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Prophylactic Role of Liposomized Chloroquine Against Murine Cryptococcosis Less Susceptible to Fluconazole</title>
<author>
<name sortKey="Khan, Masood A" sort="Khan, Masood A" uniqKey="Khan M" first="Masood A." last="Khan">Masood A. Khan</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Interdisciplinary Biotechnology Unit, Aligarh Muslim University, 202002, Aligarh</wicri:regionArea>
<wicri:noRegion>Aligarh</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Immunology and Medical Microbiology, IUPUI, Indianpolis, Indiana</wicri:regionArea>
<placeName>
<region type="state">Indiana</region>
</placeName>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Jabeen, Rukhsana" sort="Jabeen, Rukhsana" uniqKey="Jabeen R" first="Rukhsana" last="Jabeen">Rukhsana Jabeen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Interdisciplinary Biotechnology Unit, Aligarh Muslim University, 202002, Aligarh</wicri:regionArea>
<wicri:noRegion>Aligarh</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mohammad, Owais" sort="Mohammad, Owais" uniqKey="Mohammad O" first="Owais" last="Mohammad">Owais Mohammad</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Interdisciplinary Biotechnology Unit, Aligarh Muslim University, 202002, Aligarh</wicri:regionArea>
<wicri:noRegion>Aligarh</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Pharmaceutical Research</title>
<title level="j" type="sub">An Official Journal of the American Association of Pharmaceutical Scientists</title>
<title level="j" type="abbrev">Pharm Res</title>
<idno type="ISSN">0724-8741</idno>
<idno type="eISSN">1573-904X</idno>
<imprint>
<publisher>Kluwer Academic Publishers-Plenum Publishers</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2004-12-01">2004-12-01</date>
<biblScope unit="volume">21</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="2207">2207</biblScope>
<biblScope unit="page" to="2212">2212</biblScope>
</imprint>
<idno type="ISSN">0724-8741</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0724-8741</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>chloroquine</term>
<term>cryptococcosis</term>
<term>fluconazole</term>
<term>liposomes</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">No Heading: Purpose.: The prophylactic role of liposomized chloroquine (lip-CQ) has been assessed against less susceptible Cryptococcus neoformans infection in murine model. Methods.: In the current study, we investigated the antifungal activity of lip-CQ against C. neoformans in macrophages cell line (J 774) and murine model. Mice were pretreated with free as well as liposomized formulations of CQ at various doses. The anticryptococcal activity of fluconazole was compared in mice with or without CQ pretreatment. The efficacy of CQ prophylaxis was assessed by survival as well as colony forming units (cfu) in brain and lungs of treated mice. Results.: Fluconazole alone was not found significantly effective against C. neoformans in both in vitro and in vivo studies. However, the antifungal activity of fluconazole increases in chloroquine-pretreated mice. Lip-CQ was found to be more effective in comparison to the same dose of free chloroquine in reducing fungal burden from macrophages in vitro and lungs and brain of C. neoformans infected mice. Conclusions.: The enhanced prophylactic activity of lip-CQ seems due to rapid uptake of drug-containing liposomes by macrophages. The liposome-mediated accumulation of CQ in macrophages makes the environment unfavorable (alkaline) for the intracellular multiplication of C. neoformans. Moreover, the increased incidence of multidrug resistance and diversity of pathogenic microorganisms inhibited or killed by CQ makes it the drug of choice for prophylactic therapy.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Inde</li>
<li>États-Unis</li>
</country>
<region>
<li>Indiana</li>
</region>
</list>
<tree>
<country name="Inde">
<noRegion>
<name sortKey="Khan, Masood A" sort="Khan, Masood A" uniqKey="Khan M" first="Masood A." last="Khan">Masood A. Khan</name>
</noRegion>
<name sortKey="Jabeen, Rukhsana" sort="Jabeen, Rukhsana" uniqKey="Jabeen R" first="Rukhsana" last="Jabeen">Rukhsana Jabeen</name>
<name sortKey="Mohammad, Owais" sort="Mohammad, Owais" uniqKey="Mohammad O" first="Owais" last="Mohammad">Owais Mohammad</name>
</country>
<country name="États-Unis">
<region name="Indiana">
<name sortKey="Khan, Masood A" sort="Khan, Masood A" uniqKey="Khan M" first="Masood A." last="Khan">Masood A. Khan</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/an2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000249 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd -nk 000249 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    an2020
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:9917EB17E63B7F8CFEB78FB799F6C00F609F95E3
   |texte=   Prophylactic Role of Liposomized Chloroquine Against Murine Cryptococcosis Less Susceptible to Fluconazole
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021